Thai Bio Innovation Co., Ltd. (“Thai Bio”) During 2014 - 2018, Mr.Jirawat Nooritanon, Managing Director of Global Green Chemicals Public Company Limited ("GGC"), and Mr.Wanlop Thianthong
% MB % MB % 1. Wellness and Anti-aging 128.58 40.58% 162.70 43.82% 34.12 26.54% 2. Aesthetic Innovation 96.00 30.30% 67.17 18.09% (28.83) (30.03%) 3. Companion Animal Health 80.78 25.50% 132.19 35.60
& development, and innovation According to NSTDA’s guideline, the Company reported research & development, and innovation expenses at Baht 1.12 million. Finance costs The Company’s finance costs presented at
company -243.50 -59.81 -183.69 -307.12 Financial Position as at December 31 (Unit : Million Baht) 2018 2017 Inc./(Dec.) % Current Assets 423.04 305.00 118.04 38.70 Non-Current Assets 920.89 259.75 661.14
Innovation 2.94 3.03 24.11 28.39 (21.17) (87.80%) 3. Companion Animal Healthcare 43.06 44.33 25.70 30.26 17.35 67.51% 4. Livestock 3.36 3.45 3.25 3.82 0.11 3.36% Total Sales Revenue 97.13 100.00 84.93 100.00
PowerPoint Presentation DR.TEERAPON TANOMSAKYUT CHIEF INNOVATION & SUSTAINABILITY OFFICER TRUE CORPORATION PUBLIC COMPANY LIMITED 7 MARCH 2022 TRUE’S TASK FORCE ON CLIMATE RELATED FINANCIAL
INNOVATION PUBLIC COMPANY LIMITED PM THORESEN ASIA HOLDINGS PUBLIC COMPANY LIMITED POLARIS CAPITAL PUBLIC COMPANY LIMITED POLYNET PUBLIC COMPANY LIMITED PORN PROM METAL PUBLIC COMPANY LIMITED POWER LINE
Experiment and Develop Innovation In Support of Service Provision Related to Capital Market _____________________ By virtue of Section 14 of the Securities and Exchange Act B.E. 2535 (1992), as amended by the
Experiment and Develop Innovation In Support of Service Provision Related to Capital Market _____________________ By virtue of Section 14 of the Securities and Exchange Act B.E. 2535 (1992), as amended by the
19 - Natural Resources Financial Position Statement of Cash Flows Statement Financial Ratios Environment Management Accounting Management Discussion and Analysis of Business Operation for Q1/2019